SCHEMBL9534618

SCHEMBL9534618

Oc1nc2ccc3nonc3c2nc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.42
ENPP2 Q13822 2/20 0.42
MAPT P10636 6/20 0.38
GAA P10253 2/20 0.38
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 5/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
USP2 O75604 1/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
HSD17B10 Q99714 3/20 0.35
CASP1 P29466 2/20 0.35
CASP7 P55210 2/20 0.35
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
HPGD P15428 2/20 0.34
NPC1 O15118 1/20 0.34
TSHR P16473 1/20 0.34
GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9532920 0.71 MAPT (0.38) POLBENPP2MAPTGAAKDM4E
SCHEMBL9533409 0.70 MAPT (0.50) MAPTGAAKDM4EALDH1A1MEN1
SCHEMBL9532647 0.68 ADRA2A (0.37) POLBMAPTGAAKDM4EALDH1A1
SCHEMBL16204096 0.67 CASP1 (0.50) POLBENPP2MAPTGAAKDM4E
SCHEMBL5984487 0.67 ACHE (0.39) MAPTGAAKDM4EALDH1A1KMT2A
SCHEMBL9534598 0.67 MAPT (0.41) MAPTGAAKDM4EALDH1A1MEN1
SCHEMBL15018032 0.67 MAPT (0.49) POLBENPP2MAPTGAAKDM4E
SCHEMBL9532539 0.66 MEN1 (0.48) POLBGAAMEN1KMT2AUSP2
SCHEMBL5543675 0.65 ACHE (0.54) POLBENPP2MAPTGAAALDH1A1
SCHEMBL9671767 0.64 LMNA (0.61) MAPTGAAKDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5109001-A Treating hyperactivity of excitatory neurotransmitters NOVO NORDISK A/S (DK) 1992-04-28 US claimed
EP-0348872-B1 FUSED DIHYDROXYQUINOXALINES AND THEIR USE AS GLUTAMATE ANTAGONISTS NOVO NORDISK A/S (DK) 1993-09-29 EP disclosed
US-5109001-A Treating hyperactivity of excitatory neurotransmitters NOVO NORDISK A/S (DK) 1992-04-28 US disclosed
US-5079250-A TRICYCLIC HETEROCYCLIC DIOLS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1992-01-07 US disclosed
US-5075306-A Nervous system, psychological disorders NOVO NORDISK A/S (DK) 1991-12-24 US disclosed
US-5057516-A Nervous system disorders NOVO NORDISK A/S (DK) 1991-10-15 US disclosed
US-4977155-A Nervous system disorders A/S FERROSAN (DK) 1990-12-11 US disclosed
EP-0348872-A1 Fused dihydroxyquinoxalines and their use as glutamate antagonists NOVO NORDISK A/S (DK) 1990-01-03 EP disclosed